G Piscitelli
Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group
Thürlimann B, Zurlo M, Lanzalone S, di Salle E, Murray R, Roché H, Bonneterre J, Serin D, Paridaens R, Piscitelli G. Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group. European journal of cancer (Oxford, England : 1990) 1997; 33:1767-73.
01.10.1997Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group
01.10.1997European journal of cancer (Oxford, England : 1990) 1997; 33:1767-73
Thürlimann Beat, Zurlo M G, Lanzalone S, di Salle E, Murray R, Roché H, Bonneterre J, Serin D, Paridaens R, Piscitelli G
Exemestane experience in breast cancer treatment
Lønning P, Paridaens R, Thürlimann B, Piscitelli G, di Salle E. Exemestane experience in breast cancer treatment. The Journal of steroid biochemistry and molecular biology 1997; 61:151-5.
01.04.1997Exemestane experience in breast cancer treatment
01.04.1997The Journal of steroid biochemistry and molecular biology 1997; 61:151-5
Lønning P E, Paridaens R, Thürlimann Beat, Piscitelli G, di Salle E